Clinical Trial Update: The Impact of Remimazolam for Postoperative Sedation on the Left Ventricular Systolic Performance in Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the impact of remimazolam for postoperative sedation on left ventricular systolic performance in cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Konkuk University Medical Center | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN